EDT Pharma Holdings and PAR Pharmaceutical Sue TWI Pharmaceuticals

  • September 7, 2011

EDT Pharma Holdings and PAR Pharmaceutical filed suit against TWI Pharmaceuticals over a patent related to nanoparticulate megestrol formulations.  9/2, Northern District of Illinois, 1:2011cv06134.


Access to the full article is currently available to RPX members only. Please contact us if you need further information.



×
×

Thank you for your feedback

×
×